Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,035 | 18,791 | 15,649 | 18,978 | 20,291 |
| Marketable Securities | 10,176 | 8,311 | 9,164 | 5,046 | 5,286 |
| Receivables | 3,207 | 4,162 | 3,728 | 2,393 | 1,815 |
| Inventories | 2,204 | 2,470 | 2,258 | 2,706 | 2,074 |
| TOTAL | $34,079 | $34,213 | $31,130 | $29,550 | $29,774 |
| Non-Current Assets | |||||
| PPE Net | 1,932 | 1,968 | 2,040 | 2,090 | 2,162 |
| Intangibles | 874 | 895 | 921 | 965 | 1,008 |
| Other Non-Current Assets | 282 | 249 | 249 | 644 | 628 |
| TOTAL | $3,088 | $3,112 | $3,209 | $3,700 | $3,797 |
| Total Assets | $37,167 | $37,325 | $34,339 | $33,250 | $33,571 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,563 | 4,727 | 3,301 | 3,196 | 3,723 |
| Other current liabilities | N/A | 6 | 17 | 74 | 79 |
| TOTAL | $4,137 | $5,431 | $3,964 | $3,892 | $5,139 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 314 | 471 | 219 | 240 | 934 |
| TOTAL | $1,475 | $1,562 | $1,570 | $1,610 | $1,637 |
| Total Liabilities | $5,613 | $6,993 | $5,534 | $5,502 | $6,775 |
| Shareholders' Equity | |||||
| Common Shares | 5,797 | 5,842 | 6,152 | 6,177 | 6,392 |
| Retained earnings | 24,125 | 22,957 | 21,269 | 20,251 | 19,076 |
| Other shareholders' equity | -185 | -199 | -260 | -237 | -167 |
| TOTAL | $31,555 | $30,332 | $28,805 | $27,749 | $26,796 |
| Total Liabilities And Equity | $37,167 | $37,325 | $34,339 | $33,250 | $33,571 |